期刊文献+

慢性心力衰竭患者血清尿酸水平的变化及其临床意义 被引量:7

暂未订购
导出
摘要 目的探讨慢性心力衰竭患者血清尿酸浓度变化及其临床意义。方法测定100例心力衰竭患者治疗前后血清尿酸,分析尿酸水平与性别、年龄、病因、心功能分级、利尿剂的使用及肾功能关系。结果慢性心力衰竭患者血清尿酸浓度在不同病因和不同性别及年龄之间无明显差别,未用利尿剂和用利尿剂者尿酸、尿素氮、肌酐差别无统计学意义。但随心功能的恶化而升高,Ⅰ~Ⅱ、Ⅲ、Ⅳ级心力衰竭血尿酸浓度分别为285.5±34.6μmol/L,352.6±98.6μmol/L,612.2±114.5μmol/L。治疗前后尿酸浓度也有差别,即EF值≤0.4时治疗前后尿酸浓度分别为598.3±75.6μmol/L和448.5±65.7μmol/L(P<0.01);而EF值>0.4时治疗前后血尿酸浓度分别为382.6±56.8μmol/L和295.5±35.7μmol/L(P<0.05)。结论慢性心力衰竭患者血清尿酸浓度升高,与心力衰竭的严重程度相关,治疗后血尿酸浓度明显下降。
出处 《江西医药》 CAS 2006年第7期480-481,共2页 Jiangxi Medical Journal
  • 相关文献

参考文献9

  • 1Alderman MH.Uric acid and cardiovascular risk.Our Opin Pharmacol,2002,2:126
  • 2Alderman MH.Uric acid in hypertention and cardiovascular diseases.Can J Cardiol,1995,15:2
  • 3Culleton BF,Larson MG,Kannel MB,et al.Serum uric acid and risk for cardiovascular disease and death,the framingham heart study.Ann Intern Med,1999,131:7
  • 4Fang J,Alderman MH,et al.Serum uric acid and cardiovascular mortality,NHANES 1 epidemiologic follow-up study,1971-1992.JAma,2000,283:2404
  • 5Levya F,Anker S,Swan JW,et al.Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.Eur Heart J,1997,18:858
  • 6Wannamethee SG,Shaper AG,Whincup PH,et al.Serum uric acid and the risk of major coronary heart disease events.Heart,1997,78:147
  • 7Berker BF.Towards the physiological function and uric acid.Free Radic Biol Med,1993,14:615
  • 8谭来勋,李言,叶心国.急性脑血管病患者血尿酸水平的研究[J].中国实用内科杂志,2000,20(12):740-741. 被引量:57
  • 9熊丽红,李度辉,胡春梅.心力衰竭患者血清尿酸水平及临床意义[J].实用医学杂志,2003,19(6):626-627. 被引量:15

二级参考文献9

  • 1孙丽沙 杨露春 等.急脑局灶性缺血后细胞凋亡的动态变化[J].卒中神经疾病杂志,1998,5(2):116-116.
  • 2Alderman MH. Uric Acid And Cardiovascular Risk. Curr Opin Pharmacol 2002, 2(2):126 - 130.
  • 3Levya F, Anker S, Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J, 1997,18(5): 858 - 865.
  • 4Ferris TF, Gorden P. Effect Of Angiotension And Norepinephrine upon Urate Clearance In Man. Am J Med, 1968, 44(3):359-365.
  • 5Levya F, Anker SD, Godsland IF, et al. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J. 1998, 19(12):1746 - 1747.
  • 6Olexa P, Olexova M, Gonsorcik J, et al. Uric acid-a marker for systemic inflammatory response in patients with congestive heart failure?. Wien Klin Wochenschr 2002, 114(5 -6) : 211 -215.
  • 7孙丽沙,卒中与神经疾病,1998年,5卷,2期,116页
  • 8陈文彬 主编.诊断学:第5版[M].北京:人民卫生出版社,2002.382~383.
  • 9苏晓灵.冠心病心力衰竭患者血清尿酸浓度变化及临床意义[J].青海医学院学报,2001,22(1):16-17. 被引量:1

共引文献69

同被引文献67

  • 1张学顺,于文广,于丽霞,张鲁阳,于瑛.山东省海阳市社区居民高尿酸血症与痛风流行病学调查[J].中华全科医师杂志,2006,5(4):216-219. 被引量:47
  • 2程纯,吴士尧,许左隽,陈寒萼.慢性心力衰竭患者血清尿酸水平变化及临床意义[J].中国综合临床,2006,22(5):398-400. 被引量:23
  • 3景宏美,秦晓同,李晓飞,袁鼎山,刘才旺,黄一红.心力衰竭患者脑钠素水平与心功能的关系[J].中国心血管病研究,2006,4(8):571-573. 被引量:13
  • 4何慕芝,蔡闯,江亚文.老年慢性心衰患者血清尿酸水平的动态变化[J].中国老年学杂志,2007,27(1):81-81. 被引量:1
  • 5Moriarity JT, Folsom AR,Iribarren C, et al. Serum uric acid and risk of coronary heart disease: athcrosclerosis risk in communities ( ARIC ) study. Ann Epidemiol, 2000, 10 : 136-143.
  • 6Delemos JA, MCguire DK, Draznir MH, et al. B-type natriuretic peptide in cardiovascular disease. Lancet, 2003,362 : 316-322.
  • 7Watanabe J,Shiba N,Shinozaki T,et al. Prognostic value of plasma brain natriuretic peptide combined with left ventricular dimensions in predicting sudden death of patients with chronic heart failure. J Card Fail, 2005,11 : 50-55.
  • 8Fang J, Aldeman MH. Serum uric acid and cardiovascular mortality: the NHANESI epiderniologic follow-up study. JAMN, 2000,283 : 404-410.
  • 9Nieto FJ,Iribarren C, Gross MD,et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis. Atherosclerosis, 2004,148 : 131-139.
  • 10Mayer SA. Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation. Am J Cardiol, 2004,93 : 1002-1006.

引证文献7

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部